Buy or sell Benchling stock pre IPO via an EquityZen fund
Benchling is a cloud-based software platform for biology researchers and research and development organizations.
About Benchling Stock
Benchling is the modern software platform purpose-built for life science R&D. Hundreds of thousands of scientists using cutting-edge techniques like CRISPR, CAR-T immunotherapy, and genetic engineering depend on our suite of cloud applications to design DNA, collaborate on experiments, manage research workflows, and make critical R&D decisions. Benchling is powering breakthrough research on biotherapeutics, biofuels, and biomaterials at leading life science companies and the world's most renowned academic labs. The company is focusing on life science collaboration, both private and public, through creating cloud-based software tools for digital DNA sequence editing, designing and running experiments, analyzing data, and sharing research. Benchling software includes an electronic lab notebook that allows researchers to document their experiments. It was founded in 2012, and is headquartered in San Francisco, California, United States.
Head of Customer Support / CX Operations
Co-Founder & CEO
Chief Marketing Officer
TechCrunch - Jul, 24 2019
New York Times - Feb, 10 2019